WILMINGTON, Del. -- DuPont today introduced an innovative medical fabric, DuPont Suprel, born from a revolutionary composite technology that provides both advanced levels of protection and comfort for healthcare professionals.
Traditional single-use medical fabrics can be uncomfortable, especially when they are worn for an extended time, and can lack the necessary fluid barrier for protecting today's healthcare professionals. Suprel nonwoven is the first in a line of upcoming medical fabrics from DuPont that are both highly protective and silky-soft.
DuPont researchers created Suprel through a unique bi-component formulation using the company's proprietary Advanced Composite Technology. Developing nearly 20 new patents for this technology, DuPont can blend the ideal properties of two different raw materials to create medical fabrics that meet specific needs. For example, Suprel is the only medical fabric available that is made of polyester - for strength - and polyethylene - for silk-like softness. It has less surface friction than other medical fabric products, allowing for greater comfort and freedom of movement. It also transfers heat away from the body quickly, adding to comfort in the operating environment. Suprel is made from continuous filament fibers and is very low linting.
Using a market-focused approach as part of its research and development, DuPont researchers developed Suprel by working closely with operating room nurses who participated in comfort studies conducted at North Carolina State University. Feedback and input on protection and comfort from the healthcare professionals were used in developing the new medical fabric.
"Suprel is the first in a line of innovative products from DuPont that will raise the bar for standards of protection and comfort in medical fabrics," said Lori Gettlefinger of DuPont Medical Fabrics. "Unlike the technology used with single polymer fabrics, this composite fabric technology will allow us to create an array of fabrics in direct response to the evolving needs of the medical industry."
Suprel will be available for commercial distribution in late summer in the U.S. and later this year in Europe and Asia Pacific regions. DuPont will be conducting in-hospital trial evaluations of Suprel for hospitals that request to review the high-tech medical fabric. Hospitals interested in participating in the evaluations can contact DuPont Medical Fabrics at 888-383-6887 or at www.MedicalFabrics.dupont.com.
Source: DuPont
IDEA in Action: A Strategic Approach to Contamination Control
January 14th 2025Adopting IDEA—identify, define, explain, apply—streamlines contamination control. Infection control professionals can mitigate risks through prevention, intervention, and training, ensuring safer health care environments and reducing frequent contamination challenges.
Balancing Freedom and Safety: When Public Health Mandates Are Necessary
January 9th 2025Public health mandates, such as lockdowns, masking, and vaccination, balance liberty and safety, ensuring critical protections during pandemics like COVID-19 while fostering long-term survival through science.
Long-Term Chronicles: Infection Surveillance Guidance in Long-Term Care Facilities
January 8th 2025Antibiotic stewardship in long-term care facilities relies on McGeer and Loeb criteria to guide infection surveillance and appropriate prescribing, ensuring better outcomes for residents and reducing resistance.
Considering Avian Flu: World Health Organization Expert Warns Against Raw Milk
January 6th 2025Drinking raw milk poses risks of disease transmission, especially with H5N1 outbreaks. Expert Richard J. Webby, PhD, advises against raw cow or goat milk consumption due to its unpredictable and significant risks.